CD44 in cancer

D Naor, S Nedvetzki, I Golan, L Melnik… - Critical reviews in …, 2002 - Taylor & Francis
CD44 is a multistructural and multifunctional cell surface molecule involved in cell
proliferation, cell differentiation, cell migration, angiogenesis, presentation of cytokines …

Application of immunohistochemistry in thyroid pathology

H Liu, F Lin - Archives of Pathology and Laboratory …, 2015 - meridian.allenpress.com
Context Accurate classification of follicular-patterned thyroid lesions is not always an easy
task on routine surgical hematoxylin-eosin–stained or cytologic fine-needle aspiration …

A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up …

I Sugitani, N Kasai, Y Fujimoto, A Yanagisawa - Surgery, 2004 - Elsevier
BACKGROUND: Several factors have been proven to be useful for classifying patients with
papillary thyroid carcinoma (PTC) into either low-or high-risk groups. However, the relative …

[图书][B] Surgery of the thyroid and parathyroid glands: expert consult premium edition-enhanced online features and print

GW Randolph - 2012 - books.google.com
Master all the relevant anatomy, surgical procedures, and workup needed for residency, and
learn to manage the difficult cases encountered by experienced surgeons. Get expert …

CD44 attenuates metastatic invasion during breast cancer progression

JI Lopez, TD Camenisch, MV Stevens, BJ Sands… - Cancer research, 2005 - AACR
Metastatic invasion is the primary cause of breast cancer mortality, and adhesion receptors,
such as CD44, are believed to be critical in this process. Historically, primary breast tumor …

[HTML][HTML] Single‐cell transcriptomic landscape reveals the differences in cell differentiation and immune microenvironment of papillary thyroid carcinoma between …

M Peng, G Wei, Y Zhang, H Li, Y Lai, Y Guo, Y Chen… - Cell & bioscience, 2021 - Springer
Background Papillary thyroid carcinoma (PTC) is the main pathological type of thyroid
carcinoma (TC). Gender is a prominent background parameter for patients with PTC. Here …

Prognostic factors in papillary thyroid cancer: an evaluation of 601 consecutive patients

P Siironen, J Louhimo, S Nordling, A Ristimäki… - Tumor Biology, 2005 - karger.com
Background: Although papillary thyroid cancer (PTC) is among the most curable cancer
types, it can be a distressing disease for those patients suffering from frequent recurrences …

shRNA against CD44 inhibits cell proliferation, invasion and migration, and promotes apoptosis of colon carcinoma cells

YS Park, JW Huh, JH Lee, HR Kim - Oncology reports, 2012 - spandidos-publications.com
CD44 is a causal factor for tumor invasion, metastasis and acquisition of resistance to
apoptosis. CD44 knockdown using inducible short hairpin RNA (shRNA) significantly …

NATH, a novel gene overexpressed in papillary thyroid carcinomas

Ø Fluge, O Bruland, LA Akslen, JE Varhaug… - Oncogene, 2002 - nature.com
In this study a replica cDNA screening (RCS) approach to identify genes differentially
expressed in papillary thyroid carcinomas (PTC) was used, as compared to non-neoplastic …

Predicting invasive phenotype with CDH1, CDH13, CD44, and TIMP3 gene expression in primary breast cancer

A Celebiler, Y Kilic, S Saydam, T Canda… - Cancer …, 2009 - Wiley Online Library
We aimed to determine changes in the expression of the genes CDH1, CDH13, CD44, and
TIMP3 to look for any relationship between them, HER2 and ESR1 expression at the RNA …